Label Capital, an early-growth equity firm partnering with the next generation of consumer brands and retail concepts, made its first investment in the French medical aesthetic start-up Innerskin, leading a €5 million funding round.
WHO: Founded by former finance executive Chrystelle Eid, the first Innerskin location opened in Paris in September 2022 with the vision of becoming the European leader in aesthetic medicine. The next-gen concept places skin health at the core of its practice to reveal the unique beauty of each individual through an offering of non-invasive procedures. The business has nine locations in France, including four clinics in Paris with a footprint of 540 square feet each, as well as hotel locations in Saint-Tropez and Courchevel, and in Galeries Lafayette department store.
WHY: The new capital will fuel the expansion of six clinics by year end, with plans of 15 to 18 new clinics in 2024. Expansion abroad could begin in 2025.
IN THEIR OWN WORDS: “Aesthetic medicine is a booming market, and there’s a huge unfulfilled demand,” Innerskin founder Chrystelle Eid told WWD. “I saw how consumers are increasingly looking for technology-based services, and there’s not much offering in Europe.”
"Very excited today to announce our first investment in Innerskin, the Paris-based company aiming to become the leader in aesthetic medicine in Europe. We are proud to be leading this €5M round alongside other great investors," Label Capital posted on LinkedIn. "From day one, Innerskin has been a beacon of achievement with already 5 locations opened (and more to come very soon…) boasting outstanding metrics and patient satisfaction, led by its visionary founder Chrystelle Eid."
DETAILS:
